Clinical Trial Update: Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study [Phase 2]

View source ↗

Summary

A Phase 2 exploratory clinical study is planned to evaluate topical 2% tofacitinib for nail psoriasis; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nail Psoriasis

Drugs mentioned

• Tofacitinib (topical) (tofacitinib)

Snippet

Sponsor: Hexsel Dermatology Clinic | Conditions: Nail Psoriasis | Phase 2 | Status: NOT_YET_RECRUITING